OCUL 10.96 (-1.26%)
US67576A1007BiotechnologyBiotechnology

Ocular Therapeutix (OCUL) Financial Metrics

This table shows a selected set of financial data points of Ocular Therapeutix (OCUL). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -1.01 0 -4.41 356.03M -0.4 58.44M -76.32M -75.42M -80.74M 195.81M
2022 -0.92 0 -3.04 216.02M -0.4 51.49M -63.32M -75.75M -71.04M 102.3M
2021 -0.09 0 -81.24 532.46M -0.03 43.52M -66.74M -75.58M -6.55M 164.16M
2020 -2.56 0 -8.08 1.26B -0.91 17.4M -54.4M -59.91M -155.64M 228.06M
2019 -1.91 0 -2.07 178.83M -1.14 4.23M -79.82M -84.58M -86.37M 54.44M
2018 -1.57 0 -2.53 151.7M -0.93 1.99M -51.12M -55.95M -59.98M 54.06M
2017 -2.2 0 -2.02 128.24M -0.97 1.92M -58.73M -59.87M -63.39M 41.54M
2016 -1.8 0 -4.65 207.71M -0.48 1.89M -35.92M -42.14M -44.7M 32.94M
2015 -1.71 0 -5.48 217.8M -0.42 1.75M -35.52M -37.27M -39.75M 30.78M
2014 -2.69 0 -8.75 250.56M -0.59 772K -21.76M -26.98M -28.65M 37.39M
2013 -0.91 0 0 0 -0.6 0 -13.03M -12.47M -13.32M 17.51M
2012 -4.77 0 0 0 0 10K -12.79M -13.31M -14.09M 23.85M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.